Preimplantation Genetic Testing for Aneuploidy (PGT-A)
Preimplantation Genetic Testing for Monogenic Disorders (PGT-M)
Clinical Whole Exome Sequencing (cWES)
Search
Saudi Arabia is undergoing a remarkable healthcare transformation under Saudi Vision 2030, with a growing focus on prevention, early diagnosis, personalized healthcare, and the development of advanced healthcare capabilities within the Kingdom. At Genalive, we are proud to contribute to this transformation by advancing the localization of genetic and genomic testing and strengthening access to specialized diagnostic services in Saudi Arabia.
Our ambition is to build on Genalive’s strong foundation and establish a sustainable national platform for advanced diagnostics and genomics. By combining advanced technologies, local laboratory and bioinformatics capabilities, scientific expertise, and strategic partnerships, we aim to reduce reliance on overseas testing, shorten turnaround times, strengthen local expertise, and ensure that critical genomic data and capabilities are developed within the Kingdom.
As healthcare moves toward a more preventive, predictive, and personalized model, genomics will play an increasingly important role in supporting clinical decisions, identifying health risks, diagnosing rare and inherited diseases, and enabling more precise approaches to patient care.
Our commitment goes beyond providing laboratory tests. We are investing in people, technology, knowledge transfer, and local capabilities to help build a stronger and more sustainable genomics ecosystem in Saudi Arabia.
Aligned with Saudi Vision 2030 and the Kingdom’s Health Sector Transformation, we will continue expanding our capabilities, strengthening partnerships across the healthcare ecosystem, and accelerating the localization of advanced genetic diagnostics—contributing to a future where world-class genomic medicine is accessible, trusted, and delivered locally.
CEO, Genalive Medical Laboratory
